The first Abiomed trade was made in Q3 2020.
Since then Ray Dalio bought shares seven more times and sold shares on two occasions. The investor sold all their shares in Q4 2022 and doesn't own any shares in Abiomed anymore.
Avg closing price
Price range
Sold -92.4 Thousand shares
Q4 2022
Avg closing price
$332.97
Price range
$242.77
-
$381.30
Increased shares by 2.4% (+2.15 Thousand shares)
Q3 2022
Avg closing price
$270.04
Price range
$242.49
-
$301.46
Increased shares by 34.9% (+23.4 Thousand shares)
Q2 2022
Avg closing price
$269.85
Price range
$224.73
-
$338.64
Increased shares by 36.5% (+17.9 Thousand shares)
Q1 2022
Avg closing price
$307.83
Price range
$277.25
-
$366.29
Increased shares by 5.3% (+2.45 Thousand shares)
Q4 2021
Avg closing price
$337.86
Price range
$300.63
-
$371.35
Sold 4.9% shares (-2.37 Thousand shares)
Q3 2021
Avg closing price
$338.77
Price range
$310.19
-
$376.20
Increased shares by 57.8% (+17.9 Thousand shares)
Q2 2021
Avg closing price
$306.77
Price range
$262.71
-
$351.17
Increased shares by 19.6% (+5.08 Thousand shares)
Q1 2021
Avg closing price
$320.02
Price range
$285.92
-
$355.13
Increased shares by 142.4% (+15.2 Thousand shares)
Q4 2020